TXN
29
4
GIS
47
13
ILMN
31
4
APH
53
3
AES
47
4
PM
49
8
EFX
43
3
CMS
57
2
CFG
36
12
ROK
46
3
PSX
24
2
AMAT
33
3
TAP
57
6
ADP
57
2
LEN
21
3
UNH
42
6
AA
27
5
FOXA
67
5
RL
73
5
OXY
42
17
TXN
29
4
GIS
47
13
ILMN
31
4
APH
53
3
AES
47
4
PM
49
8
EFX
43
3
CMS
57
2
CFG
36
12
ROK
46
3
PSX
24
2
AMAT
33
3
TAP
57
6
ADP
57
2
LEN
21
3
UNH
42
6
AA
27
5
FOXA
67
5
RL
73
5
OXY
42
17
Financhill
Back

SpringWorks Therapeutics 10K Form

Sell
32

SWTX
SpringWorks Therapeutics

Last Price:
$35.66
Seasonality Move:
4.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SWTX News And Ratings

See the #1 stock for the next 7 days that we like better than SWTX

SWTX Financial Statistics

Sales & Book Value

Annual Sales: $5.4M
Cash Flow: $-27.2M
Price / Cash Flow: 0
Annual Sales: $7.16
Price / Book: 4.98

Profitability

EPS (TTM): -3.89000
Net Income (TTM): $-275.2M
Gross Margin: $5M
Return on Equity: -51.38%
Return on Assets: -44.72%

SpringWorks Therapeutics Earnings Forecast

Key SpringWorks Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 3 years for SWTX is 92.25%.
  • The Selling, General & Administrative Expenses for SWTX have been equal to 3,626.79% of Gross Profit Margin.
  • The Research & Development expenses have been 2,762.75% of Revenue.
  • The Net Earning history of SWTX is -5,968.50% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

SpringWorks Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SWTX
CUSIP: 85205L
Website: springworkstx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.16
Quick Ratio: 5.8

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SWTX Technical Analysis vs Fundamental Analysis

Sell
32
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy or a Sell?